CAPRELSA®( vandetanib )

Drug CAPRELSA® vandetanib Caprelsa Overview This is a summary of the European public assessment report (EPAR) for Caprelsa. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Caprelsa. How is Caprelsa used? […]

CABOMETYX® (cabozantinib)

Drug CABOMETYX® cabozantinib Cabometyx Overview Cabometyx is a cancer medicine used to treat adults with: advanced renal cell carcinoma (a kidney cancer). It is used in patients who have been previously treated with a type of cancer medicine called ‘vascular endothelial growth factor (VEGF) inhibitor’. It is also used in patients who have not had […]

STIVARGA® (regorafenib)

Drug STIVARGA® regorafenib Stivarga Overview This is a summary of the European public assessment report (EPAR) for Stivarga. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Stivarga. For practical information about using Stivarga, […]

CYRAMZA® (ramucirumab)

Drug CYRAMZA® ramucirumab Cyramza Overview Cyramza is a cancer medicine used to treat adult patients with: advanced gastric cancer (cancer of the stomach) or cancer of the area where the gullet (oesophagus) enters the stomach (known as gastro-oesophageal junction adenocarcinoma). Cyramza is used in combination with another medicine, paclitaxel, or on its own if the […]

OPDIVO® (Nivolumab)

Drug OPDIVO® Nivolumab Opdivo Overview Opdivo is a cancer medicine used to treat the following: melanoma, a type of skin cancer. Opdivo is used on its own or with another cancer medicine, ipilimumab, to treat adults whose cancer has spread to other parts of the body or cannot be surgically removed. It is also used […]

LENVIMA® (lenvatinib)

Drug LENVIMA® Lenvatinib Lenvima Overview Lenvima is a cancer medicine used on its own to treat: adults with differentiated thyroid carcinoma, a type of cancer originating from the follicular cells of the thyroid gland. Lenvima is used when the cancer has progressed or spread locally or to other parts of the body, and does not […]

KEYTRUDA® (pembrolizumab)

Drug KEYTRUDA® Pembrolizumab Keytruda Overview Keytruda is a cancer medicine used to treat: melanoma, a skin cancer, non-small cell lung cancer (NSCLC), a type of lung cancer, classical Hodgkin lymphoma, a cancer of the white blood cells, urothelial cancer, a cancer of the bladder and urinary tract, a cancer affecting the head and neck known […]